Valued at $69.4M at its later-stage round, Nov 2025. Nothing has traded since.
- ·The complete investor list: 15 names
- ·Watch Vitrivax: the Monday email on marks, rounds and moves
Valuation timeline
0 priced rounds · 32 daily marks since · Sep 2026 – Oct 2026Membership and data by Private Market View
Vitrivax funding history
1 rounds| Date | Round | Raised | Post-money | $/share |
|---|---|---|---|---|
| Nov 2025 | Later Stage VC (Series B) | $29.4M | ▮ | ▮ |
Membership and data by Private Market View
Vitrivax valuation
Vitrivax was valued at $69.4 million at its later-stage round in Nov 2025. That is the last priced event on record: no secondary trade or institutional fund mark has moved the figure since.
How much has Vitrivax raised?
Vitrivax has raised $38.2 million in total; 1 of its rounds is on record. The largest on record was a $29.4 million Series B in Nov 2025.
Vitrivax has filed 1 Form D with the SEC, most recently in Nov 2025 ($29.4 million sold to 83 investors).
Comparable companies
Comparable discovery tools (healthcare) names by valuation on PrivateMarketView: Nature's Toolbox ($71 million), Xcell Biosciences ($65.5 million) and Algen ($24 million).
How Vitrivax's valuation is determined
Private company valuations aren’t quoted on an exchange — they’re established in moments: a priced funding round sets a post-money valuation, secondary trades print at a price per share, and SEC-registered funds holding the stock report fair-value marks in their N-PORT filings.
For Vitrivax, the most current credible signal sets the number and the older ones confirm it: a live secondary-market price first, then three or more recent prints, then institutional fund marks, and otherwise the last priced round, which never decays. The valuation is the last round’s post-money moved by the price change since that round, so no share count is assumed. Today it is set by its last priced round. Question about this number? Full methodology →
Frequently asked about Vitrivax
- What is Vitrivax worth?
- Vitrivax is valued at $69.4M as of Oct 2026. Valued at $69.4M at its later-stage round, Nov 2025. Nothing has traded since.
- How much has Vitrivax raised?
- Vitrivax has raised $38.2M in total funding across 1 recorded rounds.
- When did Vitrivax last raise?
- Vitrivax last raised in Nov 2025 (Later Stage VC (Series B)), raising $29.4M.